Effect of the 5-Hydroxytryptamine3(5-HT3)-Receptor Antagonist KB-R6933 0n Experimental Diarrhea Models

DOI Web Site Web Site Web Site Web Site ほか1件をすべて表示 一部だけ表示 被引用文献2件 参考文献25件

書誌事項

タイトル別名
  • Effect of the 5-Hydroxytryptamine3 (5-HT3)-Receptor Antagonist KB-R6933 on Exerimental Diarrhea Models.
  • Effect of the 5 Hydroxytryptamine3 5 HT3 Receptor Antagonist KB-R6933 0n Experimental
  • Effect of the 5-Hydroxytryptamine3 (5-HT3)-Receptor Antagonist KB-R6933 on Experimental Diarrhea Models
  • Effects of the 5-hydroxytrypyamine3 (5-HT3)-receptor antagonist KB-R6933 on experimental diarrhea models

この論文をさがす

抄録

The effects of a 5-hydroxytryptamine3 (5-HT3)-receptor antagonist KB-R6933 (6-amino-5-chloro-1-isopropyl-2-(4-methyl-1-piperazinyl)-benzimidazole dimaleate) on experimental diarrhea and on intestinal fluid secretion stimulated by cholera toxin were examined and compared with those of ramosetron and loperamide. KB-R6933 and ramosetron (0.03 - 1 mg/kg, p.o.) inhibited the diarrhea induced by 5-HT, but not that by castor oil or prostaglandin E2 (PGE2), in mice. Loperamide significantly inhibited the diarrhea induced by 5-HT, castor oil and PGE2. All drugs tested inhibited the diarrhea induced by restraint stress and the intestinal fluid secretion stimulated by cholera toxin in rats. The results suggest the possibility that KB-R6933 may have clinical efficacy in the treatment of diarrhea.

収録刊行物

  • Jpn.J.Pharmacol.

    Jpn.J.Pharmacol. 80 (1), 93-96, 1999

    公益社団法人 日本薬理学会

被引用文献 (2)*注記

もっと見る

参考文献 (25)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ